NCT07436689: Long-Term Open-Label Extension Study of Oral Levosimendan
- State
- Under way
- Phase
- Phase 3
- People
- 800 planned
- Started
- 13 Mar 2026
- Primary completion
- Mar 2029
- Arms
- TNX-103
- Results
- None posted
- 27 Feb 2026: Trial registered
- 13 Mar 2026: Trial started